You're reading the free version. Trader adds the live tape and alerts.
Start tracking
TXG Sale Disclosure
Stuelpnagel John R · SEC Form 4 · Filed Sep 8, 2026
Sale
Calculated transaction value
$423.21K
Stuelpnagel John R Director
TXG
10x Genomics
TXG
Transaction date
Sep 3, 2026
Public filing date
Sep 8, 2026
Filing lag
Filed 5 days later
TXG daily price context
Close on/before transaction
$63.22
Sep 3, 2026
First close after public filing
$67.29
Sep 9, 2026
30-day return after filing
+14.85%
Through Oct 8, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Class A Common Stock
- Quantity / price
- 6,814 shares @ $62.11
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001610717-26-000405
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$1.24M
Buys / sales
0 / 3
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| 10x Genomics, Inc. TXG | Sale | Sep 3, 2026 | $425.33K |
| 10x Genomics, Inc. TXG Current | Sale | Sep 3, 2026 | $423.21K |
| 10x Genomics, Inc. TXG | Sale | Sep 3, 2026 | $386.53K |